U.S. Aerospace & Defense Stock News

Are you eyeing IREN stock and wondering whether now is the right moment to make your move? You are definitely not alone. After a stunning 135% rise over the past three months, with a year-to-date return north of 100%, IREN has landed squarely on the watchlists of both growth seekers and cautious optimists. That kind of momentum, especially following months of volatility across tech and crypto-adjacent sectors, sends a clear message that the market is reconsidering IREN’s risk and reward...

Xenon Pharmaceuticals recently announced its second quarter and six-month 2025 earnings, reporting a net loss of US$84.71 million for the quarter and US$149.75 million for the half year, both increases from the prior year. The widening net loss, alongside a higher basic loss per share, highlights increasing costs or investments that are impacting the company’s financial performance. We’ll explore how the growing net loss shapes Xenon Pharmaceuticals’ investment narrative and what investors...

Earlier this week, Essential Properties Realty Trust announced it has priced a US$400 million offering of 5.400% senior notes due 2035, as part of its ongoing capital markets activities. This substantial debt financing initiative reflects Essential Properties Realty Trust’s intention to optimize its capital structure and potentially lower its cost of capital for future growth. With issuing US$400 million in long-term notes to manage its balance sheet, we’ll look at implications for Essential...

Fresh Del Monte Produce Inc. recently announced a joint venture with Managro Group to expand an avocado and lime packing facility in Colombia, aiming to enhance supply chain capabilities and market reach in North America and Europe. This collaboration leverages Colombia's strong agricultural conditions and supports Fresh Del Monte's efforts to diversify sourcing and grow in the high-demand avocado and lime sectors. We'll examine how this supply chain expansion in Colombia could shape Fresh...

TFS Financial recently delivered quarterly revenues that exceeded analyst expectations, with management emphasizing the company's ability to succeed in varied economic conditions. CEO Marc A. Stefanski highlighted this strong operational performance as evidence of the company's resilience and adaptability amidst changing financial climates. We'll explore how TFS Financial’s earnings surprise and consistent performance shape its overall investment narrative going forward. The best AI stocks...

Texas Capital Bancshares recently held a Non-Deal Roadshow on August 21, 2025, engaging with investors to discuss its business performance and outlook. The event highlighted ongoing market concerns about weak net interest income growth and poor net interest margin, which have raised questions about the company's profitability. We'll explore how these continuing worries around weak net interest income growth could shape Texas Capital Bancshares' future trajectory and investment...

If you have been following CG Oncology (CGON), the new attention from H.C. Wainwright might turn your head. The firm’s recent reiteration of a Buy rating, along with upbeat comments on progress for Cretostimogene, their promising therapy for hard-to-treat bladder cancer, has sparked a conversation among investors. H.C. Wainwright highlighted encouraging study results and the potential for more important data by year’s end, which could change how the market views CG Oncology’s future...

Following dovish remarks from Federal Reserve Chair Jerome Powell at the Jackson Hole symposium, major US indices rebounded as expectations for potential interest rate cuts increased, easing market concerns over high borrowing costs. This shift in outlook particularly benefited rate-sensitive sectors such as real estate investment trusts, bringing renewed attention to the operating environment for companies like Ladder Capital. To see how prospects of lower interest rates may affect Ladder...

Krystal Biotech (KRYS) has just shifted its clinical development strategy in a way that is sure to catch the eye of investors weighing what to do next. The company reported encouraging results from its inhaled KB707 trial in non-small cell lung cancer, delivering a 36% objective response rate in a tough patient group. Following this data, Krystal secured a key FDA End of Phase 2 meeting, aimed at accelerating a registration path for this therapy. At the same time, they are pausing the...

If you are staring at Monolithic Power Systems stock and wondering whether it deserves a spot in your portfolio right now, you are not alone. Lately, the buzz around MPWR has been hard to miss, both from headline-grabbing market shifts and from those quietly impressive gains stacking up over the past few years. Despite a rocky patch recently, MPWR has posted a stellar 274% jump in the past 90 days and more than doubled over the last five years, suggesting some long-term growth potential. That...

Thinking about Union Pacific (UNP) and not quite sure whether you should hold, buy more, or take profits? You are not alone. Over the past few months, Union Pacific has had investors buzzing, especially following headlines that feel straight out of a finance thriller. First came the announced $85 billion acquisition of Norfolk Southern, something that could transform the freight railroad landscape. Not surprisingly, the news sent ripples through the industry and led many to reconsider what a...

Rumble Inc. recently reported its second quarter and six-month earnings for the period ended June 30, 2025, showing quarterly sales of US$25.08 million and a net loss of US$30.22 million. While quarterly net losses remained, the company achieved higher sales year-over-year and significantly reduced its six-month net loss compared to the previous year. We'll explore how reduced six-month net losses may influence Rumble's long-term investment narrative and future growth expectations. We've...

The Toro Company (TTC) is turning heads this week following the appointment of Edric C. Funk as its new president and chief operating officer. With nearly three decades at Toro, Funk’s track record, ranging from driving technology acquisitions to leading key business segments, signals the company’s continued push into smart solutions and innovation. For investors, leadership shifts like this often act as catalysts, shaking up market sentiment and sparking fresh takes on a company’s growth...

If you are sizing up Barrick Mining and wondering if it is time to buy, sell, or hold, you are not alone. With the stock up over 21% in the last 30 days and surging more than 37% in the past three months, Barrick has been catching the eye of both seasoned investors and newcomers alike. While the gold market's momentum and improving earnings have given the share price a lift, there is always the question of whether the stock's run has left it expensive or if there is more growth ahead. When we...

Euronet Worldwide recently completed an US$850 million offering of 0.625% senior unsecured convertible notes due October 2030, issued under Rule 144A and priced at par. This sizable convertible bond issuance introduces potential future equity dilution and reflects Euronet’s appetite to access capital for ongoing digital payments growth initiatives. We’ll now examine what Euronet’s US$850 million convertible notes could mean for its long-term digital strategy and investment narrative. Rare...

In recent days, Chairman & CEO Randall Stuewe sold 62,500 shares of Darling Ingredients, and the company launched Nextida, a joint venture focused on health and wellness markets. This activity unfolds as analysts express caution over regulatory uncertainty impacting renewable diesel margins, highlighting shifts in both leadership actions and business strategy. We’ll explore how the CEO’s share sale may influence confidence in Darling Ingredients’ evolving investment narrative. Trump's oil...

Earlier this month, Atmus Filtration Technologies announced that its Board of Directors approved a quarterly cash dividend increase to US$0.055 per common share, up 10% from the previous dividend, payable on September 10, 2025 to shareholders of record as of August 26, 2025. This boost in the company's dividend payout reflects management's confidence in financial health and commitment to providing greater returns to shareholders. We will explore how this dividend increase may influence...

If you’ve been watching Ligand Pharmaceuticals (LGND) lately, you know it has just wrapped up a $400 million convertible note offering, with new senior unsecured notes coming due in 2030. This financing move brings names like Citigroup, BofA Securities, and Stifel as co-lead underwriters, signaling that the company is making deliberate efforts to bolster its financial flexibility. For investors, a convertible bond deal of this size can indicate that Ligand is seeking resources for its...

If you are eyeing MSCI and wondering whether to add it to your portfolio, you are not alone. The stock has had its share of twists and turns lately. In just the last month, MSCI shares climbed over 8%, a move that may have caught the attention of growth-oriented investors. Even with some choppy action earlier this year, as shown by its recent year-to-date decline of almost 4%, the company’s long-term run remains impressive, with a five-year return topping 61%. Clearly, the broader market...

If you have been watching Cheniere Energy (ticker: LNG), you are not alone. The stock’s story has been regularly turning heads, and recent moves on the chart have only made it more interesting for investors trying to decide whether to buy, sell, or hold. Over the past month, Cheniere Energy’s share price has climbed over 6%, with year-to-date gains at nearly 8%. Go back a year, and you are looking at about a 30% total return. In fact, looking further back, the five-year total return clocks in...

If you are weighing your next move with CoStar Group stock, you're not alone. Over the past few months, both casual investors and seasoned analysts have been following its trajectory closely, wondering if the solid gains can keep rolling or if this is the time to get cautious. CoStar Group has been on a solid run lately, up more than 23% in the last 90 days and almost 29% year-to-date. The 1-year total return clocks in at over 18%, which is certainly nothing to sneeze at, especially in the...

Affiliated Managers Group recently announced the appointment of Marcy Engel to its Board of Directors, effective September 30, 2025, coinciding with the retirement of long-serving board member Dwight D. Churchill. Engel's extensive experience in alternatives and broad leadership roles across major asset managers highlights AMG's ongoing focus on strengthening governance as it expands in specialized investment strategies. With this board addition, we'll explore how AMG's evolving leadership...

Federal Agricultural Mortgage Corporation recently completed a US$25 million fixed-income offering of 6.5% non-cumulative preferred stock, providing the company with additional capital support and funding flexibility. This development highlights Farmer Mac's ability to attract investor interest through enhanced capital offerings, particularly in an environment where yield and financial stability are closely watched. We'll examine how the successful preferred stock issuance may reinforce...

United Community Banks, Inc. recently completed the redemption of all outstanding shares of its 6.875% Series I Non-Cumulative Perpetual Preferred Stock, totaling an aggregate liquidation preference of US$88 million, and also announced a 4.2% increase in its quarterly cash dividend on common stock, payable in early October 2025. This combination of preferred stock redemption and dividend increase highlights active capital structure management and signals confidence in the company’s ongoing...